… in the Pneumocystis jirovecii pneumonia (PCP) incidence in HIV-infected patients after the
in… non-HIV-infected immunocompromised patients at risk leads to considerable epidemiologic …

… Little data exist about the pattern of the disease in immunocompromised patients … of PCP
in immunocompromised patients without AIDS and compared the results to those of patients …

… study, all immunocompromised patients with acute … fungus Pneumocystis jirovecii is
responsible for Pneumocystis pneumonia (PCP), a life-threatening infection in immunocompromised …

… options for non–AIDS immunocompromised patients who have Pneumocystis …
immunocompromised patient populations, including cancer chemotherapy and organ transplant …

… a cohort of patients with different autoimmune conditions prospectively followed during one
year. Anyway, the incidence of PcP in non-HIV immunosuppressed patients is increasing as …

… suspicion for PCP in immunocompromised patients who do … included consecutive patients
with confirmed PCP who were … confirmed PCP as a positive result for Pneumocystis jirovecii …

… Pneumocystis jiroveci pneumonia (PJP) is a severe and potentially fatal opportunistic infection
in immunosuppressed patients… patients with and without human immunodeficiency virus (…

… From an epidemiologic point of view, this high prevalence is difficult to determine if PCP
or colonized immunosuppressed patients and their close contacts are the only sources of …

… the characteristics and kinetics of pulmonary changes in Pneumocystis jiroveci pneumonia
(PJP) before and after treatment as depicted by thin-section-CT in HIV-negative patients. …

… , particularly among immunocompromised hosts [5]. In the case of Pneumocystis jirovecii, …
among immunocompromised patients assessed for PCP in a 12-year retrospective study. …